These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8213878

  • 1. Formation of neutralizing antibodies after treatment with human calcitonin.
    Grauer A, Reinel HH, Lunghall S, Lindh E, Ziegler R, Raue F.
    Am J Med; 1993 Oct; 95(4):439-42. PubMed ID: 8213878
    [Abstract] [Full Text] [Related]

  • 2. Neutralizing antibodies against calcitonin.
    Grauer A, Reinel HH, Ziegler R, Raue F.
    Horm Metab Res; 1993 Sep; 25(9):486-8. PubMed ID: 8225203
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.
    Grauer A, Raue F, Schneider HG, Frank-Raue K, Ziegler R.
    J Bone Miner Res; 1990 Apr; 5(4):387-91. PubMed ID: 2343778
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA.
    Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Formation of antibodies to synthetic human calcitonin during treatment of Paget's disease.
    Dietrich FM, Fischer JA, Bijvoet OL.
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):468-76. PubMed ID: 517048
    [Abstract] [Full Text] [Related]

  • 10. Functional significance of antibody formation after long-term salmon calcitonin therapy.
    Hosking DJ, Denton LB, Cadge B, Martin TJ.
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):243-52. PubMed ID: 572275
    [Abstract] [Full Text] [Related]

  • 11. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study.
    Pontiroli AE, Pajetta E, Calderara A, Alberetto M, Pozza G, Manganelli V, Resmini G, Tessari L, Maresca V.
    J Endocrinol Invest; 1991 Jan; 14(1):47-51. PubMed ID: 1646250
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation.
    Reginster JY, Gaspar S, Deroisy R, Zegels B, Franchimont P.
    Osteoporos Int; 1993 Sep; 3(5):261-4. PubMed ID: 8400608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An evaluation of antibodies and clinical resistance to salmon calcitonin.
    Singer FR, Aldred JP, Neer RM, Krane SM, Potts JT, Bloch KJ.
    J Clin Invest; 1972 Sep; 51(9):2331-8. PubMed ID: 4674133
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment.
    Woodhouse NJ, Mohamedally SM, Saed-Nejad F, Martin TJ.
    Br Med J; 1977 Oct 08; 2(6092):927-9. PubMed ID: 410477
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT, Hu KW, Huang BJ, Lai CH, Tu LH.
    J Phys Chem B; 2019 Dec 05; 123(48):10171-10180. PubMed ID: 31692350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.